Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENFORCE: National Cohort Study of COVID-19 Vaccines
NCT04760132Phase 4Completed
- Start
- Feb 2021
- Primary completion
- Dec 2023
- Modality
- Viral Vector Vaccines, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of tozinameran, elasomeran, ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19). Started Feb 2021; status: completed.
02
Drugs
tozinameranelasomeranChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04760132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04760132.